# Fibroblast-Targeted Nanodelivery Systems: Mechanisms of Collagen Remodeling Regulation and Novel Strategies for Scar Repair

**Authors:** Junshan Lan, Zhipeng Teng, Qian Huang, Fang Qin, Yibin Zheng, Yuting Liu, Yilin Chang, Xing Zhou, Xiaohui Li, Wenwu Wan, Lu Wang, Jie Lou

PMC · DOI: 10.3390/pharmaceutics18020172 · 2026-01-28

## TL;DR

This review explores how nanodelivery systems can target fibroblasts to regulate collagen remodeling and improve scar repair.

## Contribution

The paper introduces a framework linking fibroblast biology and nanodelivery design for scar-minimizing therapies.

## Key findings

- Fibroblast activation and differentiation into myofibroblasts drive excessive scar formation.
- NDDSs can modulate fibroblast behavior through targeted delivery and stimuli-responsive designs.
- Materials design should align with fibroblast states and wound-stage cues for effective scar repair.

## Abstract

Scar formation is a common outcome of post-injury repair and can compromise both esthetic appearance and physiological function. Fibroblasts are central mediators of this process; their aberrant activation or differentiation into myofibroblasts drives fibrosis and excessive scar tissue accumulation. Nanodrug delivery systems (NDDSs) offer unique opportunities to modulate fibroblast behavior through cell-/microenvironment-guided targeting, controlled release, and stimuli-adaptive designs. Here, we summarize fibroblast biology across scar repair and delineate the mechanistic underpinnings of scar pathogenesis. We then synthesize recent progress in NDDS-enabled interventions for pathological scarring, with an emphasis on how materials design can be matched to fibroblast states and wound-stage cues. By connecting mechanisms to delivery strategies, this review provides a framework to guide the development of scar-minimizing therapies and functional tissue regeneration.

## Full-text entities

- **Genes:** Hif1a (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 29560] {aka HIF1-alpha, MOP1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 363521] {aka Taz}, Fn1 (fibronectin 1) [NCBI Gene 25661] {aka FIBNEC, fn-1}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Fgf21 (fibroblast growth factor 21) [NCBI Gene 170580] {aka Fgf8c}, Postn (periostin) [NCBI Gene 361945] {aka Plf}, Mtpn (myotrophin) [NCBI Gene 79215] {aka Gcdp}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, Timp1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 116510] {aka TIMP-1, Timp}, Ugt1a1 (UDP glucuronosyltransferase family 1 member A1) [NCBI Gene 24861] {aka UDPGT 1-1, Udpgt, Ugt1}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], Fgf7 (fibroblast growth factor 7) [NCBI Gene 29348] {aka Fgf5b, KGF/FGF7, Kgf}, Lox (lysyl oxidase) [NCBI Gene 24914] {aka H-rev142, Rrg1}, Egf (epidermal growth factor) [NCBI Gene 25313], Pdgfrb (platelet derived growth factor receptor beta) [NCBI Gene 24629] {aka PDGFR-1}, Mmp1 (matrix metallopeptidase 1) [NCBI Gene 300339] {aka Clgn, MMP-1, Mmp1a}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 81686], Smad4 (SMAD family member 4) [NCBI Gene 50554] {aka Madh4}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 362245] {aka LC3-I, LC3-II, LC3A}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, Hgf (hepatocyte growth factor) [NCBI Gene 24446] {aka HPTA}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, Eif6 (eukaryotic translation initiation factor 6) [NCBI Gene 305506] {aka Itgb4bp, eIF-6}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 24772] {aka Sdf1}, Ptk2 (protein tyrosine kinase 2) [NCBI Gene 25614] {aka FAK, FRNK, p125FAK}, Src (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 83805], Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Rhoa (ras homolog family member A) [NCBI Gene 117273] {aka Arha, Arha2}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 25125], Pdgfra (platelet derived growth factor receptor alpha) [NCBI Gene 25267] {aka APDGFR, PDGFACE}, Fgf10 (fibroblast growth factor 10) [NCBI Gene 25443] {aka FGF-10, Fgf5a}, p53-ps (Wistar clone pR53P1 p53 pseudogene) [NCBI Gene 301300], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Sumo1 (small ubiquitin-like modifier 1) [NCBI Gene 301442], Il13 (interleukin 13) [NCBI Gene 116553], Eln (elastin) [NCBI Gene 25043] {aka RATTREL11, TREL11, Trela, Trela26}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 24770] {aka MCP-1, MCP1, Scya2, Sigje}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Sphk1 (sphingosine kinase 1) [NCBI Gene 170897], Il4 (interleukin 4) [NCBI Gene 287287] {aka Il4e12}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Ccn2 (cellular communication network factor 2) [NCBI Gene 64032] {aka CTGRP, Ctgf}, Col1a1 (collagen type I alpha 1 chain) [NCBI Gene 29393] {aka COLIA1}, Mapk14 (mitogen activated protein kinase 14) [NCBI Gene 81649] {aka CRK1, CSBP, CSPB1, Csbp1, Csbp2, Exip}, Rac1 (Rac family small GTPase 1) [NCBI Gene 363875], Actg2 (actin gamma 2, smooth muscle) [NCBI Gene 25365] {aka ACTGE, SMGA}, Tat (tyrosine aminotransferase) [NCBI Gene 24813], Yap1 (Yes1 associated transcriptional regulator) [NCBI Gene 363014] {aka YAP65, Yap}
- **Diseases:** HS (MESH:D017439), infections (MESH:D007239), keloid (MESH:D007627), cytotoxicity (MESH:D064420), hypertrophic (MESH:D002312), immune dysregulation (OMIM:614878), inflammatory skin disorder (MESH:D012868), chronic (MESH:D002908), cutaneous injury (MESH:D014947), Inflammation (MESH:D007249), fibrosis (MESH:D005355), pain (MESH:D010146), mitochondrial dysfunction (MESH:D028361), diabetic (MESH:D003920), skin atrophy (MESH:D001284), structural abnormalities (MESH:C566527), Scar (MESH:D002921), burn (MESH:D002056), hypoxia (MESH:D000860)
- **Chemicals:** Cur (-), Curcumin (MESH:D003474), silica (MESH:D012822), glycosaminoglycans (MESH:D006025), THC (MESH:C096277), imine (MESH:D007097), PVA (MESH:D011142), pba (MESH:C075773), selenium (MESH:D012643), polyphenols (MESH:D059808), 3-hydroxyvalerate (MESH:C013056), lipopeptide (MESH:D055666), Lipid (MESH:D008055), PLGA (MESH:D000077182), triamcinolone acetonide (MESH:D014222), poly(3-hydroxybutyrate-co-3-hydroxyvalerate (MESH:C052620), DHA (MESH:C039060), gold (MESH:D006046), CS (MESH:D048271), oxygen (MESH:D010100), NM (MESH:D008466), LA (MESH:D007811), water (MESH:D014867), 5-Fu (MESH:D005472), CeO2 (MESH:C030583), Peptide (MESH:D010455), 5-aminolevulinic acid (MESH:C000614854), silicone (MESH:D012828), Resveratrol (MESH:D000077185), cucurbit[7]uril (MESH:C456276), Tempo (MESH:C003959), Ce (MESH:D002563), HA (MESH:D006820)
- **Species:** Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090], Pistacia atlantica (species) [taxon 434234]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943864/full.md

---
Source: https://tomesphere.com/paper/PMC12943864